Eden Research, an agrochemical and encapsulation development company, is all set to start trading on AIM on May 11th.
Zeus Capital Limited is acting as nominated adviser (nomad) and broker in relation to the admission to AIM and the market capitalisation of the company at admission is expected to be in the region of £20.54m.
Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company is developing these technologies through research and a series of commercial production, marketing and distribution partnerships.
The ticker symbol for the company will be EDEN.
JH
-
Shein shifts IPO focus to Hong KongThe development piles fresh pressure on London’s beleaguered stock market, which many had hoped would be boosted by Shein’s IPO
-
Scientists turn lead into gold – could it wreck the yellow metal's price?Medieval alchemists have been vindicated after scientists turned lead into gold, but the results aren’t going to crash the gold price any time soon
